- February 11, 2015 | BY
Collecting evidence on the immunological makeup of syngeneic tumor cell lines could be uniquely valuable in cancer immunotherapy.
- February 9, 2015 | BY
After years of debate, the FDA is poised to approve its first biosimilar. What comes next?
- February 2, 2015 | BY
With the economy improving, how will R&D spending fare this year?
- January 26, 2015 | BY
Check out Ken Henderson’s article in R&D Magazine on using exhaust air dust (EAD) testing to improve the health of animal research colonies.
- January 22, 2015 | BY
A scientist’s view of public interests in animal research and welfare.
- January 15, 2015 | BY
Seven tips for ensuring a reliable, reproducible immunopotency assay in vaccine testing.
- January 8, 2015 | BY
How a small CRO’s early discovery project led to the approval of Belinostat.
- December 22, 2014 | BY
Is in vivo imaging the next revolution in drug development?
- December 19, 2014 | BY
The evolution in understanding of disease mechanism and a revolution in techniques to produce novel biotherapeutics have resulted in a growing class of compounds effective in treating the most difficult diseases.
- December 18, 2014 | BY
Trying to understand the bone’s newfound connection to immune system and microbiome. It’s a marathon not a sprint.